Viewing Study NCT02446405


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-03-11 @ 6:06 PM
Study NCT ID: NCT02446405
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-06
First Post: 2015-05-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Sponsor: University of Sydney
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module